acetylcysteine

Type: Keyphrase

Name: acetylcysteine

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Investigators at Jagiellonian University Target Depression

(NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Mental Health is now available. According to news originating from Krakow, Poland, by NewsRx correspondents, research stated, "The growing body of evidence implicates the ... [Published NewsRX - Apr 25 2013]

Entities: Jagiellonian University, oxidative stress, Antioxidants, N-acetylcysteine, Biological Psychiatry

First reported Apr 12 2013 - Updated Apr 13 2013 - 1 reports

Green Valley Drugs: Recall of all sterile products

The FDA have stated that the pharmacy company has issued a recall notice for all of its products intended to be sterile. The alert comes via the U.S. Food and Drug Administration (FDA) Medwatch service. The message indicates that notified healthcare professionals ... [Published Digital Journal - Apr 12 2013]

Entities: Aseptic, Asepsis, Drugs

Quotes

...studies and new international partnerships for India and Indonesia," said A J Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "We were also pleased with the first quarter financial results maintaining revenues from the prior year quarter, while significantly increasing our net income through the efficient management of our expenses."

Cumberland Pharmaceuticals Reports First Quarter Financial Results [Published Individual.com - May 02 2013]

According to the news editors, the research concluded: "Our study further supports the antidepressant-like activity of NAC and links its effect as well as IMI actions with the enhancement of brain SOD activity."

Investigators at Jagiellonian University Target Depression [Published NewsRX - Apr 25 2013]

"An ophthalmically acceptable liquid may include a preservative. The preservative may vary, and may include any compound or substance suitable for preventing microbial contamination in an ophthalmic liquid subject to multiple uses from the same container. Preservatives that may be used in the pharmaceutical compositions disclosed herein include, but are not limited to, cationic preservatives such as quaternary ammonium compounds including benzalkonium chloride, polyquad, and the like; guanidine-based preservatives including polyhexamethylene biguanide (PHMB), chlorhexidine, and the like; chlorobutanol; mercury preservatives such as thimerosal, phenylmercuric acetate and phenylmercuric nitrate; and oxidizing preservatives such as stabilized oxychloro complexes (e g. Purite.RTM.). Purite.RTM. is a registered trademark of Allergan Inc."

Patent Application Titled "Compositions for the Treatment of. . . [Published Equities.com - Apr 25 2013]

More Content

sort by: Date \| Relevance
Cumberland Pharmaceuticals Reports First Quarte... [Published Individual.com - May 02 2013]
Investigators at Jagiellonian University Target... [Published NewsRX - Apr 25 2013]
Patent Application Titled "Compositions for the... [Published Equities.com - Apr 25 2013]
Green Valley Drugs: Recall of all sterile products [Published Digital Journal - Apr 12 2013]
Solid dosage form that promotes reliable oral, ... [Published PharmCast - Mar 14 2013]
InnoPharma, Inc. Announces U.S. FDA Approval of... [Published PR Newswire: Policy & Public Interest - Jan 08 2013]
Cumberland Pharma gets second Acetadote patent ... [Published PharmaBiz - Nov 09 2012]
Grant us anosmia! [Published Silicon India - Oct 29 2012]